Annalise Enterprise CXR
by Annalise.ai
An AI-assisted chest X-ray decision-support system from Annalise.ai. It analyzes adult chest radiographs for numerous radiological findings and provides clinicians with secondary review and worklist-prioritization support.
Why Abandoned
Annalise.ai continues to maintain an official product page for Enterprise CXR and lists current regulatory and product information. No verified shutdown or acquisition of the product was found.
🩺 Health Signals
- HTTP Status
- 403
- Response
- —
- SSL
- —
- Confidence
- 90%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
Annalise CXR launched in Australia
Annalise.ai announced the Australian launch of its chest X-ray AI decision-support product, developed with radiology provider I-MED Radiology Network.
Series B funding announced
Annalise.ai announced an AU$129 million Series B round led by Skip Capital and Main Sequence Ventures to support international expansion and product development.
FDA clearance announced
Annalise.ai announced U.S. FDA 510(k) clearance for Annalise CXR as a triage and notification device covering specified chest X-ray findings.
Expanded FDA clearance announced
The company announced an additional FDA clearance broadening Annalise CXR's U.S. indications to eight findings on chest X-rays.
🔄 Alternatives to Annalise Enterprise CXR
Hugging Face
🟢ActiveThe GitHub of machine learning — hosting models, datasets, and AI applications.
Bard / Gemini
🟢ActiveGoogle's AI assistant, originally Bard, rebranded to Gemini with multimodal capabilities.
Microsoft Copilot
🟢ActiveMicrosoft Copilot is a generative AI assistant available on the web, Windows, mobile devices, and Microsoft Edge. It answers questions, drafts and summarizes text, creates images, and can connect with Microsoft services.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Annalise Enterprise CXR?
Annalise Enterprise CXR is AI-based clinical decision-support software that reviews adult chest X-rays and highlights suspected radiological findings for clinicians.
How does Annalise Enterprise CXR work?
It applies trained medical-imaging models to chest radiographs, then presents suspected findings and related decision-support information within a radiology workflow. Availability of individual features depends on local regulatory clearance.
What can Annalise Enterprise CXR detect?
The global product is designed to identify a broad range of chest X-ray findings. The exact supported findings and intended use vary by country and regulatory authorization, so users should consult local labeling.
Is Annalise Enterprise CXR FDA cleared?
Yes. Annalise.ai has announced U.S. FDA 510(k) clearances for Annalise CXR triage and notification capabilities, including an expanded set of eight findings. FDA-cleared functionality is narrower than some versions marketed elsewhere.
Who uses Annalise Enterprise CXR?
It is intended for healthcare organizations and clinicians interpreting adult chest radiographs, including radiology departments, hospitals, and imaging networks. It supports rather than replaces clinical judgment.